Digital Pathology Market to Grow with a CAGR of 11.46% through 2030
Increasing integration of AI in healthcare and increasing prevalence of cancer is expected to drive the Global Digital Pathology Market growth in the forecast period, 2026-2030.
According to TechSci Research
report, “Digital Pathology Market - Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the Global Digital Pathology Market stood
at USD 1.16 billion in 2024 and is anticipated to grow with a CAGR of 11.46%. One
of the primary driving factors behind the growth of the global digital
pathology market is the increasing prevalence of generic and rapid
technological advancements in digital pathology systems. This factor has
significantly contributed to the expansion of the digital pathology market over
the forecast period. Additionally, the rising incidence of cancer cases plays a
crucial role in driving the growth of the digital pathology market. Moreover,
the growing prevalence of chronic and cardiovascular diseases acts as an
additional factor that boosts the digital pathology market. The utilization of
Artificial Intelligence (AI) has also demonstrated its effectiveness in
comparison to previous techniques used for identifying and evaluating
pathological characteristics. The implementation of AI has expedited and
strengthened the diagnostic process, as well as enhanced the success and
cost-efficiency of drug discovery. These advancements have greatly propelled
the digital pathology market over the forecast year.
Furthermore, digital
pathology has played a significant role in companion diagnostics and drug
development pipelines, encompassing molecular biology, bio banking, molecular
tissue profiling, and tissue microarray analysis. The increasing demand for
high-quality tissue samples in tissue-based biomarker research is projected to
drive the adoption of digital pathology in the market over the forecast period.
The digital pathology market
is driven by several factors, including the increasing number of
teleconsultations, the rising adoption of digital pathology to enhance
laboratory efficiency, and its expanding application in drug discovery and
companion diagnostics. The integration of digital pathology with digital tools,
barcoding, specimen tracking, and digital dictation has also contributed to the
growing use of digital pathology in disease diagnosis. These integrations have
improved the safety, quality, and efficiency of disease diagnoses in pathology
laboratories. According to a report published by the World Health Organization
(WHO), digital pathology is expected to have significant potential in making
routine pathology practice more efficient and accurate by 2022, owing to its
ease of use and the ability to work remotely. Additionally, artificial
intelligence (AI)-based assistance systems have been employed to enhance image
processing in diagnostic sectors, providing clinicians and specialists with quicker
and safer judgments in radiology or pathology practices, as reported by
Deontics Ltd in September 2022.
The integration of digital
pathology with digital tools such as barcoding, specimen tracking, and digital
dictation has improved the safety, quality, and efficiency of disease diagnosis
in pathology laboratories. The digital pathology platform allows for the
instant sharing of whole slides among multiple pathologists, enabling
collaborative input on cases. For example, in January 2021, Roche launched
uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis for
breast cancer, using automated digital pathology algorithms with artificial
intelligence. These algorithms assist pathologists in making rapid and accurate
diagnoses, supporting the determination of the most effective treatment
strategies for each patient. Consequently, the utilization of digital pathology
for disease diagnosis is expected to grow steadily in the forecast period
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on "Global
Digital Pathology Market”
The Global Digital Pathology
Market is segmented into product type, application, end user, regional
distribution, and company.
Based
on application, the disease diagnosis segment is anticipated to experience
rapid growth, driven by the escalating prevalence of chronic illnesses and
manufacturers' dedication to developing advanced and swift diagnostic
techniques. These techniques aim to facilitate seamless exchange of information
between different departments. The adoption of digital technologies plays a
vital role in improving the efficiency of disease diagnosis and enhancing
therapeutic interventions. For instance, in April 2022, PreciseDx collaborated with
The Michael J. Fox Foundation to unveil AI-powered digital pathology technology
for early diagnosis of Parkinson's disease, even before severe symptoms
manifest in patients.
Asia Pacific is growing exponentially in the digital pathology market due to rapid advancements in healthcare infrastructure, increasing focus on early disease detection, and the region’s strong push toward medical digitization. Countries like China, India, and Japan are investing significantly in digital health technologies, with rising adoption of telepathology and AI-powered diagnostic tools. The growing burden of chronic diseases, especially cancer, is prompting healthcare providers to seek efficient and accurate diagnostic solutions. Additionally, the shortage of pathologists in many countries within the region is accelerating the shift toward digital workflows. Expanding government initiatives and growing acceptance of digital health solutions are further fueling market growth across Asia Pacific.
Major companies
operating in Global Digital Pathology Market are:
- 3DHISTECH
- Corista
- Aiforia Technologies Oy
- Akoya Biosciences
- OptraSCAN
- Glencoe Software
- QProscia Inc
- Kanteron Systems
- Mikroscan Technologies
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“Digital pathology offers an enhanced viewing experience,
thereby improving analysis and reducing diagnostic error rates. These tools
also provide service providers with immediate access to previous cases for
comparison, facilitating long-term predictive analysis through data storage.
Barcoding specimens minimizes the risk of misidentification and eliminates
concerns about lost data due to slide breakage. The market growth of digital
pathology systems is expected to be driven by increasing technological advancements.
For example, according to an article published in the Visceral Medicine Journal
in 2021, digital pathology has witnessed technological advancements in
artificial intelligence and label-free imaging. The utilization of artificial
intelligence in digital pathology is growing in tandem with the development of
slide scanners, the abundance of data generated, and the ever-increasing
computing power. The growth of the global digital pathology market is primarily
driven by the increasing prevalence of cancer, the growing demand for accurate
diagnostics, and the development of new digital pathology systems by numerous
key players”, said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“Digital Pathology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Scanners, Software, and Storage & Communication Systems), By Application (Disease Diagnosis, Teleconsultation, Drug Discovery, Training & Education), By End User (Pharmaceutical & Biotechnology Companies, Hospitals and Clinics, Academics Institutes & Research Laboratories), By Region and Competition, 2020-2030F”, has evaluated the future
growth potential of Global Digital Pathology Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Digital Pathology Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
M: +13322586602
Email: [email protected]
Web: https://www.techsciresearch.com